Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 776.87B | 824.77B | 727.40B | 552.18B | 526.00B |
Gross Profit | 363.08B | 421.16B | 363.85B | 265.85B | 259.85B |
EBITDA | 286.09B | 283.97B | 248.42B | 171.94B | 162.92B |
Net Income | 178.32B | 224.61B | 192.99B | 121.79B | 110.50B |
Balance Sheet | |||||
Total Assets | 2.09T | 1.93T | 1.77T | 1.54T | 1.39T |
Cash, Cash Equivalents and Short-Term Investments | 511.29B | 623.50B | 697.05B | 640.55B | 560.76B |
Total Debt | 13.07B | 12.19B | 11.54B | 10.79B | 11.52B |
Total Liabilities | 208.69B | 225.62B | 210.68B | 159.88B | 137.27B |
Stockholders Equity | 1.88T | 1.70T | 1.56T | 1.38T | 1.25T |
Cash Flow | |||||
Free Cash Flow | -6.10B | 27.24B | 75.16B | 91.18B | 85.63B |
Operating Cash Flow | 98.21B | 101.62B | 156.09B | 120.47B | 124.61B |
Investing Cash Flow | -131.90B | -87.09B | -116.22B | 73.44B | 24.92B |
Financing Cash Flow | -87.93B | -113.30B | -88.93B | -56.01B | -49.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $17.48B | 29.12 | 17.15% | 0.92% | -0.25% | -7.32% | |
74 Outperform | $12.19B | 27.76 | 15.54% | 1.44% | 1.98% | -7.66% | |
71 Outperform | $39.07B | 40.77 | 28.46% | 1.49% | -8.23% | -3.29% | |
63 Neutral | $31.88B | 62.62 | 5.21% | 0.10% | 4.67% | -36.65% | |
62 Neutral | $12.59B | 26.99 | 12.25% | 1.67% | 4.73% | -19.15% | |
60 Neutral | $20.34B | 21.80 | 7.46% | 1.40% | 0.86% | -18.22% | |
58 Neutral | HK$13.62B | 5.49 | -2.78% | 5.72% | 2.29% | -57.50% |